A detailed history of Princeton Capital Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Princeton Capital Management LLC holds 6,992 shares of BMY stock, worth $352,746. This represents 0.14% of its overall portfolio holdings.

Number of Shares
6,992
Previous 7,660 8.72%
Holding current value
$352,746
Previous $393,000 3.56%
% of portfolio
0.14%
Previous 0.16%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

SELL
$47.98 - $54.4 $32,050 - $36,339
-668 Reduced 8.72%
6,992 $379,000
Q4 2023

Feb 08, 2024

SELL
$48.48 - $57.85 $56,818 - $67,800
-1,172 Reduced 13.27%
7,660 $393,000
Q3 2023

Nov 13, 2023

SELL
$57.89 - $64.73 $140,441 - $157,034
-2,426 Reduced 21.55%
8,832 $512,000
Q2 2023

Aug 14, 2023

SELL
$63.71 - $70.74 $54,026 - $59,987
-848 Reduced 7.0%
11,258 $719,000
Q1 2023

May 01, 2023

SELL
$65.71 - $74.53 $1.88 Million - $2.13 Million
-28,560 Reduced 70.23%
12,106 $839,000
Q4 2022

Jan 31, 2023

SELL
$68.48 - $81.09 $370,819 - $439,102
-5,415 Reduced 11.75%
40,666 $2.93 Million
Q3 2022

Nov 10, 2022

SELL
$0.13 - $76.84 $95 - $56,707
-738 Reduced 1.58%
46,081 $3.28 Million
Q2 2022

Aug 15, 2022

SELL
$72.62 - $79.98 $1.25 Million - $1.37 Million
-17,175 Reduced 26.84%
46,819 $3.61 Million
Q1 2022

May 11, 2022

BUY
$61.48 - $73.72 $6,516 - $7,814
106 Added 0.17%
63,994 $4.67 Million
Q4 2021

Feb 09, 2022

SELL
$53.63 - $62.52 $67,841 - $79,087
-1,265 Reduced 1.94%
63,888 $3.98 Million
Q3 2021

Nov 10, 2021

SELL
$59.17 - $69.31 $26,744 - $31,328
-452 Reduced 0.69%
65,153 $3.86 Million
Q2 2021

Aug 11, 2021

BUY
$61.91 - $67.42 $20,554 - $22,383
332 Added 0.51%
65,605 $4.38 Million
Q1 2021

May 12, 2021

SELL
$59.34 - $66.74 $74,293 - $83,558
-1,252 Reduced 1.88%
65,273 $4.12 Million
Q4 2020

Feb 11, 2021

BUY
$57.74 - $65.43 $173,046 - $196,093
2,997 Added 4.72%
66,525 $4.13 Million
Q3 2020

Nov 12, 2020

BUY
$57.43 - $63.64 $125,427 - $138,989
2,184 Added 3.56%
63,528 $3.83 Million
Q2 2020

Aug 10, 2020

BUY
$54.82 - $64.09 $102,513 - $119,848
1,870 Added 3.14%
61,344 $3.61 Million
Q1 2020

May 13, 2020

BUY
$46.4 - $67.43 $111,963 - $162,708
2,413 Added 4.23%
59,474 $3.64 Million
Q4 2019

Feb 12, 2020

BUY
$49.21 - $64.19 $6,840 - $8,922
139 Added 0.24%
57,061 $3.78 Million
Q3 2019

Nov 14, 2019

SELL
$42.77 - $50.71 $37,979 - $45,030
-888 Reduced 1.54%
56,922 $2.89 Million
Q2 2019

Aug 12, 2019

SELL
$44.62 - $49.34 $115,208 - $127,395
-2,582 Reduced 4.28%
57,810 $2.62 Million
Q1 2019

May 02, 2019

BUY
$45.12 - $53.8 $64,295 - $76,665
1,425 Added 2.42%
60,392 $2.88 Million
Q4 2018

Feb 13, 2019

SELL
$48.76 - $63.23 $1.57 Million - $2.04 Million
-32,227 Reduced 35.34%
58,967 $3.07 Million
Q3 2018

Nov 08, 2018

SELL
$55.19 - $62.25 $1.58 Million - $1.78 Million
-28,545 Reduced 23.84%
91,194 $5.66 Million
Q2 2018

Aug 02, 2018

SELL
$50.53 - $62.98 $58,917 - $73,434
-1,166 Reduced 0.96%
119,739 $6.63 Million
Q1 2018

May 03, 2018

SELL
$59.92 - $68.98 $443,707 - $510,796
-7,405 Reduced 5.77%
120,905 $7.65 Million
Q4 2017

Feb 12, 2018

BUY
$59.94 - $65.35 $7.69 Million - $8.39 Million
128,310
128,310 $7.86 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $107B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Princeton Capital Management LLC Portfolio

Follow Princeton Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Princeton Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Princeton Capital Management LLC with notifications on news.